FDA to discuss user fees for OTC monographs

13 May 2016 - Deborah Wilkes

The US Food and Drug Administration (FDA) has announced a public meeting on the "potential development of a user-fee programme for OTC monograph drugs". The agency said it was "critically under-resourced" in this regulatory area.